Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2024 06:58 ET | Source: Research and Markets

Percutaneous Transluminal Angioplasty Markets Report, 2020-2024 & 2025-2030 Featuring Medtronic, Terumo, Cardinal Health, Boston Scientific, Teleflex, J&J, Abbott, Stryker, BD and Co, and Cook

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By...
October 24, 2023 04:43 ET | Source: Research and Markets

Coronary Artery Disease Global Market Research Report 2023

Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global coronary artery disease...
May 15, 2023 07:53 ET | Source: Research and Markets

Global Coronary Artery Disease (CAD) Market Analysis/Forecast Report 2023-2028 Featuring AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, Merck & Co, Viatris, Sanofi, & Amgen

Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease (CAD) Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
October 26, 2022 07:48 ET | Source: Research and Markets

Worldwide Precision Cardiology Industry to 2027 - by Offering, Sample Type, Technology, Application, End-user and Region

Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Precision Cardiology Market: Competition Forecast and Opportunities to 2027" report has been added to ResearchAndMarkets.com's offering.The...
September 09, 2020 06:53 ET | Source: Research and Markets

Outlook on the Global Refractory Angina Industry to 2030 - 11-Year Forecast of Refractory Angina Epidemiology

Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Refractory Angina (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
December 13, 2018 07:00 ET | Source: Avinger, Inc.

Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device

REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
May 04, 2018 08:00 ET | Source: Avinger, Inc.

Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018

REDWOOD CITY, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
April 30, 2018 08:30 ET | Source: Avinger, Inc.

Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018

REDWOOD CITY, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next...
March 29, 2018 09:00 ET | Source: Avinger, Inc.

Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris

REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne...